immuno oncology frontiers world miami


Dorit Harati

Dorit Harati

Vice President, Quality Assurance, Manufacturing & Logistics, Gamida Cell
Dorit Harati is the VP Quality Assurance and Manufacturing at Gamida Cell. She has 27 years of experience in the pharmaceutical and biotechnology industries. 
At Gamida Cell Dorit is responsible for the Quality Assurance department with all the tasks necessary to manage a facility that works in accordance with international regulations, verifying proper drug development, transfer of projects from the R&D laboratories to manufacturing in GMP facilities, manufacturing at Gamida Cell, technology transfer to different CMOs and routine work at the CMOs, establishing logistics systems to support the manufacturing of time-sensitive batch per patient products at different facilities to different transplant centers worldwide, using external laboratories and being responsible for a Qualified Person for the European transplant centers. 
Prior to joining Gamida Cell, Dorit served as the director of the quality control laboratories at Perio Products Ltd., a pharmaceutical company specializing in manufacturing innovative drugs. While at Perio Products she implemented quality systems in accordance with FDA  and European regulations.
  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy